Nicholas Glanville

Nicholas Glanville has a long history of work experience in the research field. In 2010, they began as a Postdoctoral Research Associate at Imperial College London. In 2017, they moved to Therapeutic Frontiers Ltd as a Senior Scientist. In 2019, they took on the role of Principal Scientist at VirTus Respiratory Research Ltd. Currently, they are a Director Preclinical Research and Head of Immunology at Prokarium.

Nicholas Glanville holds a Doctor of Philosophy (PhD) in Immunology from Imperial College London, obtained between 2006 and 2010, and a Bachelor of Science (BSc) in Biology, General from Kingston University, obtained between 2002 and 2005. Nicholas also holds the Project Fundamentals Qualification from the Association for Project Management, obtained in November 2018.